Percutaneous Mitral Valve Repair Devices Market Scope
Mitral regurgitation is treated with percutaneous mitral valve repair (MVR), a minimally invasive procedure (MR). The mitral valve connects the heart's two left chambers (the left atrium and the left ventricle). Mitral valve regurgitation occurs when the mitral valve is not properly closed, allowing blood to flow backward into the heart. Adults and the elderly are more likely to develop MR, which is caused by valve degeneration caused by age or genetic influence. The demand is growing due to an increase in the geriatric population and an increase in mitral valve disorders. In addition, the rise in technological advances, as well as the launch of novel mitral valves, are driving market development.
The Percutaneous Mitral Valve Repair Devices market study is segmented by Type (Mechanical Valves and Bioprosthetic Tissue (Biological) Valves), by Application (Cardiovascular, Oncology, Neurology, Urology and Others) and major geographies with country level break-up.
Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Percutaneous Mitral Valve Repair Devices market throughout the predicted period.
AbbottLaboratories (United States), Colibri Heart Valve (United States), Edwards Lifesciences Corporation (United States), LivaNova PLC (United Kingdom), Medtronic (Ireland), NeoChord, Inc(United States), CryoLife Inc (United States), Boston Scientific Corporation (United States), Micro Interventional Devices, Inc (United States) and JenaValve Technology, Inc (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Heart Leaflet Technologies(United States), Auto Tissue Berlin GmbH (Germany), Micro Interventional Devices, Inc (United States) and JenaValve Technology, Inc (Germany).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
AMA Research has segmented the market of Global Percutaneous Mitral Valve Repair Devices market by Type, Application and Region.
On the basis of geography, the market of Percutaneous Mitral Valve Repair Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Current guidelines give Class IIb recommendations for Percutaneous mitral valve repair in symptomatic patients secondary to chronic severe primary MR despite optimal goal-directed medical therapy. Patients should have favourable anatomy and reasonable life expectancy but prohibitive surgical risk due to severe comorbidities. and The U.S. Food and Drug Administration has approved a new indication for a heart valve repair device that is intended to reduce moderate-to-severe or severe mitral regurgitation, a leakage of blood backward through the mitral valve into the heart’s left atrium that can cause heart failure symptoms such as shortness of breath, fatigue and swelling in the legs.
Market Trend
- Rising Use of Pipeline Devices in Various Applications
Market Drivers
- Growth in geriatric population and Rise in Mitral valve Disorders
- High Prevalence of Cardiovascular Diseases
- Various Awareness Programs and Conferences
Opportunities
- Improving Healthcare Infrastructure in Developing Countries
Restraints
- High Treatment Cost
- High Cost of Devices
Challenges
- Product Approvals & Safety Concerns
Key Target Audience
Manufacturers of Mitral Valve Repair Devices, Suppliers of Mitral Valve Repair Devices, Wholesalers, Distributors and Retailers of Mitral Valve Repair Devices, Healthcare Industry, Regulatory Bodies and Others